Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

transdermal preparation

A technology for transdermal absorption preparations and absorption accelerators, which is applied in the direction of antifungal agents, aerosol delivery, medical preparations of non-active ingredients, etc., and can solve the problems that it is difficult to provide transdermal absorption and difficult to pass through membranes. , to achieve excellent transdermal properties, reduce burden, and improve medication compliance

Active Publication Date: 2015-11-25
APPILI THERAPEUTICS INC
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the octanol / water partition coefficient of compound A in the pH range of 3 to 9 is less than 0.05, which is very different from the partition coefficient (100 to 1000) of general compounds with high membrane permeability
Compound A tends to be difficult to permeate through membranes, and it is difficult to provide a transdermal preparation of Compound A or a salt thereof having sufficient transdermal absorbability for exerting pharmacological effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • transdermal preparation
  • transdermal preparation
  • transdermal preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] 3 parts of active ingredients, 5 parts of oleyl alcohol, 10 parts of propylene glycol, 70 parts of ethanol and 12 parts of purified water were mixed to obtain 100 parts of the preparation.

Embodiment 2

[0064] 3 parts of active ingredients, 2 parts of oleyl alcohol, 20 parts of propylene glycol, 20 parts of 2-propanol, 30 parts of ethanol and 25 parts of purified water were mixed to obtain 100 parts of the preparation.

Embodiment 3

[0066] 3 parts of active ingredients, 5 parts of octanoic acid, 10 parts of propylene glycol, 70 parts of ethanol and 12 parts of purified water were mixed to obtain 100 parts of the preparation.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a safe, transdermal absorption preparation useful in the treatment of fungal infections, having excellent skin permeability and strong antifungal activity, and greatly contributing to a patient's quality of life. The disclosed transdermal absorption preparation contains 4-{3-[4-(3-{4-[amino (imino) methyl] phenoxy} propyl)-1-piperidinyl] propoxy} benzamidine, or a salt thereof, and a transdermal absorption enhancer.

Description

technical field [0001] The present invention relates to transdermal absorption preparation of aromatic amidine derivatives effective in treating fungal infection. Background technique [0002] Severe deep mycoses such as invasive candidiasis are often fatal. In the past, it was believed that the main defense mechanism of the host body against fungi such as Candida was the non-specific immunity of neutrophils. When this defense mechanism is functioning properly, the risk of infection with the fungus is minimal. However, in recent years, due to the increase in the number of patients suffering from underlying diseases that lower the immune function of the body such as malignant tumors (especially hematopoietic malignant tumors such as acute leukemia or malignant lymphoma) and AIDS, frequent use of anticancer agents or immunosuppressants, Heavy use of antibiotics or steroid hormones, long-term use of central venous hypertrophy or venous catheterization, etc., increase the risk...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/445A61K9/06A61K9/08A61K9/70A61K47/10A61K47/12A61K47/14
CPCA61K9/0014A61K9/08A61K31/445A61K47/10A61P31/10
Inventor 久保佳子河野良司吉村美咲城瑠美
Owner APPILI THERAPEUTICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products